Content about Medicinal chemistry

October 11, 2012

A company that manufactures simplified packaging designed to increase medication adherence has launched a new website to promote the product.

HUNT VALLEY, Md. — A company that manufactures simplified packaging designed to increase medication adherence has launched a new website to promote the product.

Medicine-On-Time announced the launch of a new website that connects patients to pharmacies that offer the packaging. The launch includes 250 pharmacies around the country, a number that the company expects to grow. The packaging system is geared toward patients taking multiple drugs and uses personalized pill cups labeled with the day, date and time to take them.

October 11, 2012

The National Association of Chain Drug Stores has announced that it will participate in the annual U.S. Senate Health Fair, which will take place on Oct. 11 to 12 in the U.S. Senate Office complex on Capitol Hill in Washington, D.C.

ALEXANDRIA, Va. — The National Association of Chain Drug Stores has announced that it will participate in the annual U.S. Senate Health Fair, which will take place on Oct. 11 to 12 in the U.S. Senate Office complex on Capitol Hill in Washington, D.C.  

The U.S. Senate Health Fair will offer thousands of Senate employees — including Hill staffers, Capitol Hill Police officers and other employees — an opportunity to receive healthcare advice and care, highlighting the essential role community pharmacy plays in the healthcare delivery system.  

October 5, 2012

The National Community Pharmacists Association on Thursday commended a bipartisan group of 13 U.S. representatives for a letter they jointly sent to the Drug Enforcement Administration requesting “clarification, guidance and collaboration,” and suggesting that the federal agency’s efforts in addressing supply chain issues of controlled substances across Florida-based distribution centers and pharmacies may be inadvertently preventing patients from accessing certain prescription drugs for which they have legitimate medical needs and prescriptions.

ALEXANDRIA, Va. — The National Community Pharmacists Association on Thursday commended a bipartisan group of 13 U.S.

October 2, 2012

Two companies have signed a deal to provide access to real-time medication history to healthcare providers.

NASHVILLE, Tenn. — Two companies have signed a deal to provide access to real-time medication history to healthcare providers.

Pharmacy management services provider PDX and healthcare revenue and payment cycle management and clinical information exchange services provider Emdeon announced the deal Monday, whereby medication history will be delivered from PDX's Electronic Pharmacy Record to Emdeon's Clinical Exchange and then to hospitals, providers, health information exchanges, nursing facilities and ambulatory and acute inpatient facilities that request it.

October 1, 2012

The Council for Responsible Nutrition on Monday announced Jim Griffiths has been named as the association’s VP scientific and international affairs, effective Oct. 10.

WASHINGTON — The Council for Responsible Nutrition on Monday announced Jim Griffiths has been named as the association’s VP scientific and international affairs, effective Oct. 10.

October 1, 2012

Customers who nominate their favorite members of a pharmacy team at local Rite Aid stores will have a chance to win $2,500 in gift cards, the retail pharmacy chain said Monday.

CAMP HILL, Pa. — Customers who nominate their favorite members of a pharmacy team at local Rite Aid stores will have a chance to win $2,500 in gift cards, the retail pharmacy chain said Monday.

September 27, 2012

The Food and Drug Administration has approved a new drug for colorectal cancer developed by Bayer HealthCare.

SAN FRANCISCO — The Food and Drug Administration has approved a new drug for colorectal cancer developed by Bayer HealthCare.

Bayer and Onyx Pharmaceuticals announced the approval of Stivarga for colorectal cancer that has spread to other parts of the body, also known as metastatic CRC, specifically for those patients who have received treatment with currently available therapies.

Bayer developed the drug and will pay royalties to Onyx on future global net sales of the drug for cancer. The two companies will promote the drug together in the United States.

September 27, 2012

With less than six weeks until Election Day, the National Association of Chain Drug Stores grassroots advocacy program is in high gear with its NACDS RxImpact Votes program, urging pharmacy advocates to help shape pharmacy’s future through political engagement.

ALEXANDRIA, Va. — With less than six weeks until Election Day, the National Association of Chain Drug Stores grassroots advocacy program is in high gear with its NACDS RxImpact Votes program, urging pharmacy advocates to help shape pharmacy’s future through political engagement.

The nonpartisan NACDS RxImpact Votes program empowers pharmacy advocates with a toolkit of resources to show the role they can play in the election process. The program focuses its “get out the vote” campaign in three ways:

September 27, 2012

Satisfaction among customers using mail-order pharmacies to fill their prescriptions continued to decline, falling significantly below customer satisfaction with brick-and-mortar pharmacies, according to the J.D. Power and Associates "2012 U.S. Pharmacy Study" released Thursday.

WESTLAKE VILLAGE, Calif. — Satisfaction among customers using mail-order pharmacies to fill their prescriptions continued to decline, falling significantly below customer satisfaction with brick-and-mortar pharmacies, according to the J.D. Power and Associates "2012 U.S. Pharmacy Study" released Thursday.

September 26, 2012

Cardinal Health this week announced that it is kicking off an effort to encourage its retail pharmacy customers to educate their patients about new Medicare benefits and options that will be available under the Patient Protection and Affordable Care Act starting in 2013.

DUBLIN, Ohio — Cardinal Health this week announced that it is kicking off an effort to encourage its retail pharmacy customers to educate their patients about new Medicare benefits and options that will be available under the Patient Protection and Affordable Care Act starting in 2013.

September 25, 2012

Patients diagnosed with serious disease have enough on their minds. So Walgreens is doing all it can to make it easier for them to obtain, administer and pay for their specialty and infused medicines, said Mike Ellis, VP specialty pharmacy and infusion.


Patients diagnosed with serious disease have enough on their minds. So Walgreens is doing all it can to make it easier for them to obtain, administer and pay for their specialty and infused medicines, said Mike Ellis, VP specialty pharmacy and infusion.


“The concept is to go where patients are diagnosed and where they reside. We have a large sales force who call on physicians who prescribe these types of medications. But like everything else at Walgreens, it starts with the patient.”


September 25, 2012

A vast army of some 70,000 Walgreens pharmacists, technicians, nurses and nurse practitioners, and other clinicians is poised to plug some of the gaps in the nation’s overstretched healthcare system with expanded services, greater access for patients and new solutions for providers and payers in desperate need of quality, cost-effective solutions.


A vast army of some 70,000 Walgreens pharmacists, technicians, nurses and nurse practitioners, and other clinicians is poised to plug some of the gaps in the nation’s overstretched healthcare system with expanded services, greater access for patients and new solutions for providers and payers in desperate need of quality, cost-effective solutions.


September 24, 2012

The Food and Drug Administration is creating a new task force to support the development of new drugs for bacterial infections, the agency said Monday.

SILVER SPRING, Md. — The Food and Drug Administration is creating a new task force to support the development of new drugs for bacterial infections, the agency said Monday.

The FDA said the Antibacterial Drug Development Task Force would assist in developing and revising guidance related to development of antibiotics, as required by the Generating Antibiotic Incentives Now Title of the FDA Safety and Innovation Act, which president Barack Obama signed into law on July 9.

September 24, 2012

During this paramount election year, the National Association of Chain Drug Stores’ grassroots advocacy program — NACDS RxImpact — continues to demonstrate the importance of pharmacy advocates engaging on behalf of community pharmacy, NACDS has announced.

ALEXANDRIA, Va. — During this paramount election year, the National Association of Chain Drug Stores’ grassroots advocacy program — NACDS RxImpact — continues to demonstrate the importance of pharmacy advocates engaging on behalf of community pharmacy, NACDS has announced.

September 20, 2012

The Food and Drug Administration has approved a drug made by Acton Pharmaceuticals for asthma, the company said Thursday.

MARLBOROUGH, Mass. – The Food and Drug Administration has approved a drug made by Acton Pharmaceuticals for asthma, the company said Thursday.

The drug maker announced the approval of Aerospan (flunisolide HFA) inhalation aerosol as a maintenance treatment for asthma in patients aged 6 and older. The drug maker plans to launch the drug in early 2013.

September 19, 2012

People go to doctor offices for a variety of reasons — for annual physicals, for checkups after previous appointments, to figure out why something is acting up or if they just feel sick. Whatever the reasons, most of them walk out of the office with a prescription in hand, according to an exclusive survey of nearly 800 patients conducted by AccentHealth and DSN in late July and early August.

People go to doctor offices for a variety of reasons — for annual physicals, for checkups after previous appointments, to figure out why something is acting up or if they just feel sick. Whatever the reasons, most of them walk out of the office with a prescription in hand, according to an exclusive survey of nearly 800 patients conducted by AccentHealth and DSN in late July and early August.

September 18, 2012

The Food and Drug Administration has approved a treatment for a disease that causes brittle nails.

CHARLESTON, S.C. — The Food and Drug Administration has approved a treatment for a disease that causes brittle nails.

Innocutis announced the FDA approval of Nuvail (poly-ureaurethane) nail solution in the 16% strength. The drug is used to treat nail dystrophy, which causes fragile and brittle nails that crack and split.

One of the most common forms of nail dystrophy is brittle nail syndrome, which affects about 20% of the population, with women disproportionately affected. Patients with the condition report that their nails are painful and impair daily activities.

September 18, 2012

The interest in healthcare reform has reached a new high, especially in light of the decision by the U.S. Supreme Court to uphold the Patient Protection and Affordable Care Act, yet there's no denying that consumers are still unclear as to the impact on their personal healthcare and insurance issues. That being said, Americans see a need for change as they battle rising costs and a lack of access to care, and many are saying "aye" to healthcare reform, according to the most recent Patient Views infographic. To be specific, two-thirds of respondents say they support healthcare reform, according to an exclusive survey of nearly 800 patients conducted by AccentHealth and DSN in late July and early August.

The interest in healthcare reform has reached a new high, especially in light of the decision by the U.S. Supreme Court to uphold the Patient Protection and Affordable Care Act, yet there's no denying that consumers are still unclear as to the impact on their personal healthcare and insurance issues. That being said, Americans see a need for change as they battle rising costs and a lack of access to care, and many are saying "aye" to healthcare reform, according to the most recent Patient Views infographic.

September 18, 2012

There was something that jumped out at me during the one-hour interview with Walgreens president and CEO Greg Wasson that helped set the tone for the massive, 86-page exclusive report on the company that appears in this issue. It had to do with Wasson’s vision for the role of community pharmacy in the future of 
health care.


There was something that jumped out at me during the one-hour interview with Walgreens president and CEO Greg Wasson that helped set the tone for the massive, 86-page exclusive report on the company that appears in this issue. It had to do with Wasson’s vision for the role of community pharmacy in the future of 
health care.


September 17, 2012

The Food and Drug Administration has approved a generic ulcer treatment made by Wockhardt, the Indian drug maker said Monday.

PARSIPPANY, N.J. — The Food and Drug Administration has approved a generic ulcer treatment made by Wockhardt, the Indian drug maker said Monday.

Wockhardt announced the approval and launch of lansoprazole delayed-release capsules in the 15-mg and 30-mg strengths. The drug is a generic version of Prevacid, which Takeda markets in the United States.

The drug has a market of about $700 million in the United States, according to IMS Health.

September 17, 2012

A lot of people have quite a few things to say about healthcare reform, whether they favor or oppose it. But supporters of the law show an altruistic sensibility and an understanding of how the law would benefit other Americans, according to an exclusive survey of nearly 800 patients conducted by AccentHealth and DSN in late July and early August.

A lot of people have quite a few things to say about healthcare reform, whether they favor or oppose it. But supporters of the law show an altruistic sensibility and an understanding of how the law would benefit other Americans, according to an exclusive survey of nearly 800 patients conducted by AccentHealth and DSN in late July and early August.

September 17, 2012

VoicePort has launched its new appointment scheduler services application.

ROCHESTER, N.Y. — VoicePort has launched its new appointment scheduler services application.

Part of the company's platform of unified patient communications, the app is a self-serve interface for patients to schedule a host of health-and-wellness appointments through a pharmacy's website.

September 14, 2012

Costs are the biggest concern for opponents of healthcare reform. They’ve done the math — additional healthcare consumers means care that’s both more expensive and harder to come by. As many as 3-in-4 consumers who are not big fans of healthcare reform share that concern — 30% of those consumers suggested it’s their greatest concern, according to an exclusive survey of nearly 800 patients conducted by AccentHealth and DSN in late July and early August. A reduction in care quality was concern No. 2 (62%), and a lack of choice over which practitioner to see was concern No. 3 (58%). But at least they’ll still be covered — only 22% said they were concerned their employers would stop the coverage.

Costs are the biggest concern for opponents of healthcare reform. They’ve done the math — additional healthcare consumers means care that’s both more expensive and harder to come by. As many as 3-in-4 consumers who are not big fans of healthcare reform share that concern — 30% of those consumers suggested it’s their greatest concern, according to an exclusive survey of nearly 800 patients conducted by AccentHealth and DSN in late July and early August. A reduction in care quality was concern No.

September 13, 2012

The Food and Drug Administration has approved a generic psychiatric drug made by Lupin Pharmaceuticals, Lupin said Thursday.

BALTIMORE — The Food and Drug Administration has approved a generic psychiatric drug made by Lupin Pharmaceuticals, Lupin said Thursday.

The Indian drug maker announced the approval of escitalopram tablets in the 5-mg, 10-mg and 20-mg strengths, used for acute and maintenance treatment of major depressive disorder in adults and adolescents and for acute treatment of general anxiety disorder in adults.

September 12, 2012

When all things are equal — particularly, cost! — there is no doubt that satisfied pharmacy customers are fiercely loyal to their preferred stores. But like Cyndi Lauper once sang, "Money changes everything," particularly for the 32% of Patient Views respondents who said they would be willing to change pharmacies for a savings of $5 or less, according to an exclusive survey of nearly 800 patients conducted by AccentHealth and DSN in late July and early August.

When all things are equal — particularly, cost! — there is no doubt that satisfied pharmacy customers are fiercely loyal to their preferred stores. But like Cyndi Lauper once sang, "Money changes everything," particularly for the 32% of Patient Views respondents who said they would be willing to change pharmacies for a savings of $5 or less, according to an exclusive survey of nearly 800 patients conducted by AccentHealth and DSN in late July and early August. How low will they go? Eight percent would switch for less than a buck.